Radionuclide therapy in the united kingdom in 1995

Nuclear Medicine Communications

Volumn 20, Issue 8, 1999, Pages 711-718

  Clarke, S E M ^a   Clarke, D G ^a   Prescod, N ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; ETIDRONIC ACID RE 186; IODINE 131; PHOSPHORUS 32; RADIOPHARMACEUTICAL AGENT; STRONTIUM 89; YTTRIUM 90;

ARTICLE; BONE PAIN; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; NEUROENDOCRINE TUMOR; PUBLIC HOSPITAL; RADIOISOTOPE THERAPY; TEACHING HOSPITAL; THYROID CANCER; THYROID DISEASE; TREATMENT INDICATION; UNITED KINGDOM;

CERTIFICATION; GREAT BRITAIN; HOSPITALS, DISTRICT; HOSPITALS, TEACHING; HUMANS; NEOPLASMS; NUCLEAR MEDICINE; QUESTIONNAIRES; RADIATION ONCOLOGY; RADIOISOTOPES; RADIOTHERAPY;

EID: 0032707047     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199908000-00005     Document Type: Article

References (4)

1. Rowell NP. Survey of attitudes of UK clinical oncologists towards radionuclide therapy. Clin Oncol (in press).
2. Institute of Health Services Management Health and Social Services Year Book. Kingston-upon-Thames: Croner Publications, 1995.
3. Elliott AT, Elliott FM, Shields RA. UK nuclear medicine survey, 1992-93. Nucl Med Commun 1996; 17: 3-7.
4. Hoefnagel CA, Clarke SEM, Fischer M et al. Radionuclide therapy practice and facilities in Europe. Eur J Nucl Med (in press).